Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Liabilities and Shareholders Equity (2020 - 2025)

Bio Essence has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $422474.0 for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 50.33% year-over-year to $422474.0; the TTM value through Dec 2025 reached $1.1 million, down 79.7%, while the annual FY2025 figure was $422474.0, 50.33% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $422474.0 at Bio Essence, up from $184534.0 in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $2.8 million in Q4 2023 and troughed at $112692.0 in Q2 2025.
  • A 5-year average of $1.4 million and a median of $1.7 million in 2021 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 78.23% in 2023 and later tumbled 94.62% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $1.7 million in 2021, then fell by 8.92% to $1.5 million in 2022, then surged by 78.23% to $2.8 million in 2023, then tumbled by 89.81% to $281024.0 in 2024, then soared by 50.33% to $422474.0 in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for BIOE at $422474.0 in Q4 2025, $184534.0 in Q3 2025, and $112692.0 in Q2 2025.